CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Pharma's Boonton, NJ site received DEA Schedule II-III registration, expanding integrated development and clinical supply services for OINDPs.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.